| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4026079 | Ophthalmology | 2014 | 8 Pages |
Abstract
Brinzolamide 1% and brimonidine 0.2% fixed combination administered BID had a significantly greater IOP-lowering effect than either brinzolamide or brimonidine alone and displayed a safety profile consistent with its individual components.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Tin FRCS, PhD, Guna MD, Tania Josefina MD, James D. MD, Alexis MD, PhD, Ivan AM, FRANZCO,